保险干扰电生理学:恢复对及时心脏护理的控制
Jalaj Garg1, Dhanunjaya Lakkireddy2
1Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California.
Heart rhythm
|October 12, 2025
概括
预先授权 (PA) 延迟了基本的电生理学 (EP) 护理,影响了患者的治疗结果和健康公平. 本分析探讨了EP中PA的障碍,并提出了简化获得关键治疗的政策解决方案.
科学领域:
- 心脏病学 心脏病学
- 卫生政策 卫生政策
背景情况:
- 预先授权 (PA) 的目的是确保适当的医疗治疗,但往往会造成严重的延误和拒绝.
- 第三方保险公司使用复杂的规则,可能无视医学协会的指导方针,限制患者获得护理.
- 导航PA的负担在很大程度上落在医疗保健提供者身上,特别是在电生理学 (EP) 等时间敏感领域.
研究的目的:
- 检查事先授权如何阻碍基本的电生理学疗法.
- 分析PA相关延迟对患者结果,临床工作流程和健康公平的影响.
- 调查PA问题的根本原因,并探索改善访问的政策解决方案.
主要方法:
- 审查事先授权对EP程序和治疗的影响.
- 分析EP护理延迟如何影响患者的治疗结果和工作流程.
- 研究医疗保健事先授权的系统问题和政策影响.
主要成果:
- 预先授权是及时和必要的电生理学干预的重要障碍.
- 由PA引起的延迟可能会对患者的结果产生负面影响,扰乱临床工作流程,并加剧健康不平等.
- 当前的PA过程往往忽视了既定的医疗准则,导致患者的护理不足于最佳水平.
结论:
- 预先授权在电生理学中是一个关键的挑战,需要紧急的政策改革.
- 简化PA过程至关重要,以确保患者及时获得拯救生命的EP疗法.
- 解决PA障碍的根本原因可以改善患者的治疗结果,提高医疗保健的效率,并促进健康公平.
相关概念视频
Mechanism of Cardiac Arrhythmias
1.6K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.6K
Disturbances in Heart Rhythm
2.5K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.5K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
465
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
465
Dysrhythmias VI: Management of Dysrhythmias
431
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
431
Electrophysiology of Normal Cardiac Rhythm
8.8K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
8.8K
Acute Coronary Syndrome IV: Interprofessional Care
219
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
219


